Human rhinoviruses express 2 cysteine proteases, 2A and 3C, that are responsible for 2 viral polyprotein processing. Both proteases also suppress host gene expression by 3 inhibiting mRNA transcription, nuclear export and cap-dependent translation. 4
Introduction 14
Human rhinoviruses typically infect the upper respiratory tract, and are the most 15 common etiological agent responsible for the common cold. Infections are acute, and 16 usually cause only minor symptomatic issues. However, for individuals who have 17 asthma, and the in elderly, infections are more problematic, with these groups 18 experiencing notable levels of morbidity and even mortality [1] . As a result, HRV 19 infection places a significant health burden on society that in North America alone has 20 an estimated economic impact of around $40 billion [2] . For this reason, there is a 21 need to understand in detail the drivers of HRV-induced pathology to better target 22 intervention strategies. 23 Rhinoviruses belong to the enterovirus genus, and are themselves subdivided into 3 24 genetically distinct species (HRV-A, B and C) [3] . All enteroviruses express two 25 separate proteases, 2A and 3C, which are used to usurp infected host cell functions. 26
Each protease targets different host cell substrates, as well as being responsible for 27 processing different boundaries within the viral polyprotein. In part due to the 28 requirement placed on it to process the majority of polyprotein boundaries, 3C has a 29 well-defined substrate recognition sequence but one which still allows it to target 30 proteins such as poly-A binding protein [4, 5] , Oct-1 [6] , TATA-binding protein [7, 8] , 31 CstF-64 [9] and nucleoporin 153 (Nup153) [10] . In contrast, 2A needs only to cleave 32 itself away from the viral polyprotein at its amino terminal boundary. Possibly as a 33 consequence of this, the protease has a less well-defined recognition motif, with 34 cleavage of some host substrates depending not just on active site recognition but also 35 exosite interactions as well [11, 12] . Host proteins targeted by 2A include eIF4GI [13] , 36 eIF4GII [14] , Gemin3 [15] and several nucleoporins (Nup62, 98 and 153) [16, 17] . 37 Overall, the cleavage of host proteins by 2A and 3C inhibits mRNA transcription, 38 processing, export and translation, and represents a key strategy used by the virus to 39 prevent the cell mounting a successful antiviral response. However, the relative 40 contribution that cleavage of each host substrate makes to blocking the host cell's 41 potential for new gene expression remains unclear. Certainly, 2A-dependent cleavage 42 of both forms of eIF4G correlates with the early shutdown of global cap-dependent 43 mRNA translation in the infected cell [14, 18] . However, inhibition of gene expression 44 from recently transcribed mRNAs occurs at an even earlier time point and correlates 45 with a reduction in mRNA transport from the nucleus, pointing to additionalinvolvement of cleavage of other proteins such as Nups [19, 20] . Other studies haveshown that expression of a genetically engineered TATA-binding protein resistant to 48 3C cleavage suppresses poliovirus replication [8] , consistent with the notion that the 49 reduction in transcription driven by this protease may play a contributory role in early 50 suppression of potential antiviral responses. Indeed, enteroviruses rely on active 51 transport to direct 3C into the nucleus at early time points, when it is predominantly 52 present as a 3CD precursor [21, 22] , suggesting early protease activity in this organelle 53 is important for infection. 54 There is variability both within and between HRV species in the ability of 2A to 55 cleave its substrates. Early studies found that 2A from HRV-2A cleaves eIF4GI and 56
eIF4GII at approximately similar rates [23] whereas the same protease from HRV-B14 57 displays a substrate preference for eIF4GI [18] . More recently it has been confirmed 58 that there is variation between all 3 HRV species regards the cleavage of both eIF4GI 59
and Nup [17] . Furthermore, this variation in Nup cleavage potentially correlates with 60 differences in the speed at which 2A disrupts nuclear import and export of fluorescent 61 reporter proteins, and by inference mRNA export [24] . It is therefore possible that 62 there is an inherent difference between different HRV proteases in the rate at which 63 they block new gene expression. However, measuring whether differences exist is 64 challenging. Firstly, the multifaceted nature by which the proteases inhibit gene 65 expression means that analysis has to be done using cells rather than in vitro 66 experimentation. Complications also arise from the use of infectious virus to drive 67 protease expression, in part because of differences in the rate of genome replication 68 between different strains, which in turn dictates rates of protease expression. 69
Expression of proteases from DNA or RNA constructs transfected into cells offers an 70 alternative solution to this latter problem. However, such an approach requires that 71 changes to new gene expression be detected before the proteases introduce unwanted 72 experimental variability through significantly altering their own expression. 73
In this study, we have used a dual promoter mammalian expression construct 74 co-expressing HRV proteases alongside a luciferase-reporter gene to examine 75 potential differences in the rate at which 2A and 3C switch off new gene expression. 76
Importantly, both the reporter protein and its mRNA have been engineered for rapid 77 turn-over, thus generating a system that is highly responsive to early changes imposed 78 by the proteases. We find that there are detectable differences when comparingbetween representative proteases from the three different HRV species. Furthermore, 80 the early rapid shut-down of gene expression we observe appears to be exclusively 81 due to 2A with 3C playing little or no role. 82
Methods 83
Cell lines and reagents 84 293T cells were maintained at 37°C in a 5% CO2 incubator with DMEM (Invitrogen,  85 Fisher Scientific UK Ltd, Loughborough, UK) supplemented with 10% foetal bovine 86 serum, 100 U/ml penicillin, 100 µg/ml streptomycin. Experimental treatment of cells 87 included incubation in medium supplemented with 200 µg/ml cycloheximide (Sigma, 88
Gillingham, UK) and/or 5 µg/ml actinomycin D (Cayman Chemical Cambridge 89
Bioscience Ltd, Cambridge, UK). 90
91

DNA constructs 92
Generation of some constructs relied on gene synthesis (Invitrogen, Fisher Scientific 93 UK Ltd, Loughborough, UK). In instances where this was the case, sequences ordered 94 were codon optimized for mammalian expression and then manually adjusted to 95 minimize the existence of unwanted splice donor and splice acceptor sites using the 96 online programmes HSF3 [25] and the NetGene2 server [26] . The initial plasmid 97 expressing GFP, VSV-tagged 2A and HA-tagged 3C from HRV16 was generated by 98 cloning a single synthetic DNA fragment into an in-house dual promoter plasmid via 99
EcoRI and SalI restriction sites to generate pCIPEP-A16 TAG (+/+) (see Fig. S1 for 100 sequence). Synthesized DNAs encoding for HRV-B4 and HRV-C2 proteases (Table  101 S1) were exchanged with their respective counterparts in pCIPEP-A16 TAG (+/+) using 102
ClaI and SbfI (2A) and BsiWI and SalI (3C) restriction sites. Inactivation of the 103 proteases involved a two-step PCR approach, which introduced a Cys>Ala mutation 104 in the active site of both 2A and 3C. A similar PCR-based strategy was used to 105 generate constructs expressing tag-free proteases and a 3C protease with a c-Myc 106 nuclear localization signal (PAAKRVKLD) fused directly to its C-terminus. Primer 107 sequences are available on request. 108
The synthetic DNA encoding for the Thioredoxin-Nanoluciferase(Nluc)PEST 109 fusion protein linked by a peptide derived from translating the hepatitis delta virus 110 (HdV) ribozyme sequence (HdV WT Nluc; Fig. S2 protease transcript experiments) to confirm loading and RNA integrity; the decision to 190 use parallel blots being based on probe signal overlap coupled with an inability to 191 strip membranes when using BrightStar detection. Images were captured on film. 192
Immunofluorescent Imaging 194
Cells seeded on glass coverslips were transfected using Fugene HD and subsequently 195 fixed with ice-cold 4% paraformaldehyde in phosphate buffered saline. 
Statistical analysis 204
Pairwise comparisons were made using a paired Students t-test. Analysis of three or 205 more experimental groups was undertaken using a repeated measures ANOVA 206 applying Greenhouse-Geisser correction to identify within-subject effect differences 207 and adjusting for multiple comparisons using Bonferroni when undertaking 208 subsequent pairwise comparisons. 209
Results 211
Producing a co-expression system for 2A and 3C. 212 A series of PolII-based constructs was generated that produced a tricistronic mRNA 213 where translation of the first cistron was under the control of an HCV IRES and 214 translation of the latter two cistrons were under the control of EMCV IRESes. GFP 215 was placed within the first cistron while the second and third cistrons encoded an N-216
terminal VSV-tagged 2A and N-terminal HA-tagged 3C protease respectively, both of 217 which were expressed as ubiquitin fusion products (Fig. 1a) . that all four expressed GFP to detectable levels (Fig 1b) . Western blot analysis of 228 transfected cell lysates ( should lead to a shutdown of cap-dependent translation while enhancing IRES-246 dependent translation [18] . To examine this, the protease expressing constructs were 247 co-transfected into cells with a bicistronic reporter plasmid that expressed renilla and 248 firefly luciferase through a cap and EMCV-IRES dependent mechanism respectively 249 (Fig. 1d) . A decrease in the ratio of renilla:firefly was only seen in A16 verified that a single major transcript of the expected size was produced from each 265 (Fig. 2a) . Furthermore, the abundance of this transcript was similar when comparing 266 between all (-/-) constructs and when comparing between all (+/+) constructs, 267 although consistent with earlier Northern blot analysis, expression of the active 268 proteases did reduce transcript abundance. 269
Western analysis confirmed that all constructs expressed GFP, VSV-tagged 270 2A and HA-tagged 3C (Fig. 2b) . Importantly, cleavage of AUF1 and eIF4G1 was 271 seen in all (+/+) lanes, verifying that each of the three different 2A and 3C proteases 272 were being expressed in an active form. While the levels of GFP, 2A and 3C were far 273 higher in all (-/-) lanes compared to all (+/+) lanes, differences were also observedwhen comparing within the (+/+) or (-/-) groups. One of the more subtle differences 275 was that seen for GFP expression, with this protein being slightly lower and slightly 276 higher in the B4(+/+) and B4(-/-) group respectively compared to the other protease 277 active and inactive constructs. Expression of 3C was similar when comparing between 278 (-/-) groups but showed reduced expression in the B4(+/+) experimental group 279 compared to the other (+/+) groups. Interestingly, expression levels of 2A were more 280 varied compared to GFP and 3C, and were less consistent between experiments, 281 particularly when comparing between the different (+/+) groups (Fig. S3) . Prior 282 indirect evidence suggest that 2A stability may vary to some degree between 283
isolates [24] and based on our data ( 
expression. 294
A highly dynamic reporter system exhibiting rapid turnover of both mRNA and 295 protein should allow shut down of new gene expression by the HRV proteases to be 296 detected before this event has a pronounced impact on HRV protease expression 297 itself. However, the intrinsic mechanisms adopted by the cell to limit mRNA half-life, 298 such as the positioning of AU rich regions within mRNA 3' untranslated regions and 299 nonsense-mediated decay, are themselves subject to regulation and often manipulated 300 by viruses [30, 31] . It was therefore desirable to have a system where mRNA was 301 destabilised in a manner that was independent of normal host regulatory pathways. To 302 achieve this a destabilized Nluc coding region was linked to an upstream thioredoxin 303 coding region via a Hepatitis Delta Virus (HdV) ribozyme sequence, thus generating a 304 single continuous ORF that should be subject to internal cleavage (Fig 3a) . Nluc transfected cells (Fig. 3b) . Cells were also transfected with the same constructs 314 and then treated with either cycloheximide (CHX) or actinomycin D (ActD). 315
Monitoring of luciferase activity (Fig. 3c) showed that the CHX-imposed block to 316 translation resulted in an early rapid drop in luciferase activity that was similar in 317 speed when comparing HdV wt -Nluc to HdV ko -Nluc, as was expected. In contrast, the (Fig. 5a) , again allowing the data to be normalize to this time point. 374
At 2 hours post transfection, no significant difference was observed among the 4 375 experimental groups, but from 3 hours onwards luciferase values from the protease 376 inactive A16 TAG (-/-) construct continued to rise and were significantly higher than the 377 three other protease active constructs which instead had declining luciferase values 378 (Fig. 5b) . When comparing between the different protease active constructs there was 379 also a trend at 3 and 4 hours for A16 analysis of cells transfected with these constructs (Fig. 6a) confirmed that that GFP 389 was present and that both eIF4GI and AUF1 cleavage occurred, demonstrating that 390 both 2A and 3C were being produced in an active form. Transfection of the equivalent 391 constructs expressing the HdV WT Nluc reporter was then used to assess the rate at 392 which new gene expression was inhibited by these tag-free proteases. Similar to 393 previous experiments, the luciferase signal at 1 hour was the same when comparing 394 across the 4 experimental groups (Fig. 6b) , allowing data to be normalized to this first 395 time point reading. Interestingly, in contrast to the results from the protease active 396 tagged constructs, a difference was seen between A16 TAG (-/-) and all untagged 397 protease active constructs at 2 hours which reached significance for A16 NT (+/+) and 398 C2 NT (+/+) (p<0.05) and was almost significant for B4
NT (+/+) (p=0.053) (Fig. 6c) . 399
For all subsequent time points the luciferase activity from all active protease 400 constructs was significantly different from that produced by the A16 (Fig. 6c) . Importantly, this difference reached significance at the 3 hour 405 time point before disappearing at later time points (Fig. 6d) (Fig. 7a and b) . Consistent with earlier experiments using tag-free 435 constructs, while luciferase levels were broadly comparable across the different 436 experimental groups 1 hour post transfection (Fig. 7a) an NLS-containing 3C was more effectively targeted to the nucleus (Fig. 8) . Based on 451 this accumulated data using both epitope tagged and non-tagged constructs, we 452 conclude that 2A plays an almost exclusive role in shutting down new gene 453
expression. 454
Discussion 458
To our knowledge, this is the first study to examine whether the combined 459 activity of 2A and 3C from different HRV species differ in capacity to block new 460 gene expression. It is also the first to assess the relative contribution each protease 461 makes to achieving this goal. While analysis was restricted to a single isolate from 462 each HRV species, we nonetheless found that there were differences between isolate 463 proteases. It is almost certain that there are many viral factors, in addition to protease-464 directed inhibition of gene expression, that contribute to HRV pathogenicity, 465 including receptor usage [33] [34] [35] [36] [37] and viral replicative capacity at both upper 466 respiratory (34ºC) and lower respiratory (37ºC) tract temperatures [38] . Nonetheless, 467
given our observation that HRV-A proteases appear more effective at inhibiting new 468 gene expression than the proteases from other HRV species, it is worth noting that it 469 is this same species, along with HRV-C, that have been suggested by some studies to 470 be associated with severest disease [39] [40] [41] . 471
Interestingly, it took substantially longer to observe an effect on gene 472 expression in the presence of active 3C versus active 2A. After plasmid transfection, 473 the latter protease started to exert an effect on reporter gene expression with 3 hours, 474
and by ~5 hours inhibition reached near maximal levels (~85% inhibition compared to 475 protease inactive control plasmid). In contrast, 3C failed to have a noticeable impact 476 on reporter gene expression until 6 hours, and even at this point inhibition was 477 marginal (Fig. 6b) . Indeed, 3C seemed to have a minimal impact above and beyond 478 that imposed by 2A, as we also failed to see any noticeable difference in inhibition of 479 reporter gene expression when only 2A activity was present in the cell compared to 480 when the activity of both proteases were present. Of course, our data do not provide 481 an accurate estimate of the window of time between when the two proteases impact 482 on gene expression in an infected cell, given that the rate of protease expression in our 483 pol II-based assay will be different to that of the former scenario. For instance in an 484 infected cell, once 2A inhibition of cap-dependent translation is complete, IRES-485 dependent translation would increase and drive more rapid production of both 2A and 486 3C [42] . Infected cells would also experience a rapid and continuous increase in viral 487 transcript which would likely drive heightened levels of protease expression beyond 488 that achievable using transfection. Both these two factors could well shorten the 489 window of time between when 2A inhibits gene expression and when 3C starts tohave an effect. Nonetheless, whatever timescales operate during HRV infection, 2A 491 would appear to inhibit host gene expression considerably earlier than 3C. This 492 observation both parallels and complements a recent study, published during the 493 preparation of this manuscript, showing that 2A rather than 3C is responsible for 494 blocking the intrinsic antiviral response in enterovirus-infected cells [43] . What then is 495 the selective advantage gained by 3C targeting processes involved in gene expression, 496
and most specifically transcription, given the evidence that this activity is important 497 for viral replication [8] ? Several possibilities present themselves. Firstly, while HRV 498 3C cleaves Oct-1[21] , most of the studies looking at the effect of enterovirus infection 499 on mRNA transcription and its importance have been done with poliovirus. It is 500 therefore possible that HRV does not actively target mRNA transcription in the same 501 way as poliovirus. Consistent with the view point that HRV might not depend on 502 rapid shut-down of mRNA transcription is the recent observation that unlike 503 poliovirus, HRV fails to use 3D to suppress mRNA splicing [44] . A second possible 504 explanation relates to the observation that while most gene transcription is quickly 505 suppressed by enteroviruses, a minority of transcripts -some with antiviral activity -506 are both upregulated and translated [45, 46] . If one assumes 2A is responsible for the 507 more widespread global inhibition of transcription and translation, 3C may be acting 508 to help suppress those genes that bypass 2A inhibition. Alternatively, inhibition of 509 transcription by enteroviruses may not be principally aimed at blocking protein 510 expression, but instead may serve to prevent production of RNA transcripts with 511 direct antiviral functions such as microRNAs [47] . Blocking nuclear RNA transcript 512 production more generally might also enhance ribonucleotide availability for viral 513 genome replication. Finally, it is possible that 3C inhibition of gene transcription is 514 more restricted when expressed as a mature product rather than a 3CD precursor. 515
Selective subcellular targeting alone seems unlikely to be able to facilitate such a 516 restriction, as we found that active targeting of 3C to the nucleus made little 517 difference on its ability to shut-down gene expression. However, alternative 518 possibilities are that 3D binds host proteins thus facilitating interaction with 3C, or 3D 519 subtly alters 3C substrate recognition. There is certainly precedence for such ideas, 520
given that 3C cleavage of the enterovirus capsid protein [48] and the TIR-domain-521 containing adapter-inducing interferon-β [49] is dependent on enterovirus and 522 hepatitis A virus 3C being expressed as a 3CD precursor. [44] . It would be interesting 523 to know whether transcription was inhibited more rapidly as a result of expressing 3Cor 3CD, assuming it was possible to achieve balance expression levels and target 525 these proteins to the nucleus. 526
A technical development that made this study possible was the generation of a 527 reporter construct that produced a highly destabilized mRNA, allowing rapid 528 detection of changes to gene transcription, mRNA maturation and mRNA export. 529
While the use of cis-acting ribozymes to control gene expression is a strategy that has 530 been used by others [50, 51] , to our knowledge this is the first study to use a ribozyme 531 as substitute to more traditional mRNA destabilizing approaches for the purposes of 532 producing a reporter mRNA with a shortened translational half-life. Selection of the 533
HdV ribozyme in this study over the more often favoured hammerhead ribozyme was 534 due to the former RNA exhibiting a slow rate of folding [52] . Both this feature, 535 combined with the introduction of an intron within the HdV ribozyme so as to deposit 536 an exon-junction complex on the ribozyme sequence, were expected to minimize 537 mRNA cleavage prior to nuclear export. A clear advantage to using an HdV ribozyme 538 in this way is that its impact on mRNA stability is not subject to regulation, unlike 539 that of endogenous RNA destabilizing pathways such as recognition of AU-rich 540 elements and nonsense-mediated decay. Importantly both these two decay pathways 541 are modulated/usurped in virus-infected cells, potentially compromising their ability 542 to be used in studies such as ours [30, 31, [53] [54] [55] [56] . Given that the apparent half-life of 543 our reporter signal after transcription termination compares favourably with that of 544 other dynamic reporter systems [57] , we believe it offers certain benefits that may 545 make it useful for other studies. 546
Epitope tagging of proteins is an effective means of monitoring expression levels in 547 cells when other suitable immunological reagents are lacking, and has been used in 548 the past for studies looking the impact of 2A and 3C in cells [10, 32] . We found that 549 while tagged proteases continued to display activity towards their respective 550 substrates, 2A had diminished activity regards the early inhibition of reporter gene 551 expression. Processing of the N-terminus of 2A is a cis-acting event, demanding that 552 carboxy-terminal end of VP1 lies across the active site of 2A prior to cleavage. We 553 therefore suspect that the epitope tag is sterically hindering substrate access to the 554 active site of 2A in a way that uniformly suppresses protease activity for all 3 species. 555
Consistent with this notion, the trend in inhibition of host gene expression by the three 556 different HRV species proteases remained the same, irrespective of whether theproteases were tagged or not, with HRV-A16 being more active than B4 or C2. Future 558 studies need to be aware of the potential problems using amino-terminal epitope 559 tagged 2A constructs when assessing protease activity. 560
In conclusion, natural variation in rhinovirus protease activity translates into 561 measurable differences in the speed at which the proteases are able to block gene 562 expression from the infected host cell nucleus. This almost certainly will influence 563 pathogenicity, although the extent to which it does so remains to be determined. 564
Further work is needed to establish whether the activity of proteases from a larger 565 sample of HRV isolates follow the same pattern as observed in this study, and 566 determine whether such variation relates to clinical outcome. 567 
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